We are live on ! Find out more
ORIAW

Orion Biotech Opportunities Corp. Warrant
ORIAW

Delisted

ORIAW was delisted on the 28th of April, 2023.

31 hedge funds and large institutions have $2.18M invested in Orion Biotech Opportunities Corp. Warrant in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

18% more capital invested

Capital invested by funds: $1.85M → $2.18M (+$331K)

7% more funds holding

Funds holding: 2931 (+2)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
31
Holders Change
+2
Holders Change %
+6.9%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
1
Closed
1
Calls
$549K
Puts
Net Calls
+$549K
Net Calls Change
+$5K
Name Holding Trade Value Shares
Change
Change in
Stake
DCM
26
DG Capital Management
New York
$3K
JG
27
Jefferies Group
New York
$2.38K
WA
28
Whitebox Advisors
Minnesota
$2K
CS
29
Clear Street
New York
$1K
CH
30
CVI Holdings
Delaware
$1K
CCM
31
Context Capital Management
California
-$3K -20,300 Closed
UBS Group
32
UBS Group
Switzerland
+$194 +897 New